Other
FX Effect on Cash
Alnylam Pharmaceuticals FX Effect on Cash decreased by 662.0% to -$7.06M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 150.2%, from $14.06M to -$7.06M. Over 2 years (FY 2021 to FY 2024), FX Effect on Cash shows a downward trend with a 30.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Reflects global exposure; does not indicate operational performance but highlights the sensitivity of cash holdings to currency market volatility.
Detailed definition
Represents the impact of fluctuations in foreign currency exchange rates on the company's cash and cash equivalent balan...
Peer comparison
Standard for multinational corporations with significant international operations and cash holdings.
Metric ID:
fx_effectHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.08M | -$3.14M | -$3.05M | -$2.24M | -$8.84M | $2.02M | $2.18M | -$130.00K | -$6.55M | $10.90M | -$9.94M | -$3.12M | $15.09M | -$17.27M | $14.06M | $27.51M | -$927.00K | -$7.06M |
| QoQ Change | — | -390.4% | +2.8% | +26.6% | -294.8% | +122.9% | +7.5% | -106.0% | <-999% | +266.3% | -191.2% | +68.6% | +583.8% | -214.4% | +181.4% | +95.7% | -103.4% | -662.0% |
| YoY Change | — | — | — | — | -917.3% | +164.5% | +197.2% | +98.5% | -423.7% | — | -556.8% | <-999% | +330.4% | -258.5% | +241.4% | +981.6% | -106.1% | -150.2% |
Range-$17.27M – $27.51M
CAGR+55.5%
Avg YoY Growth-207.6%
Median YoY Growth-106.1%
Current Streak2 quarters decline
FX Effect on Cash at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's fx effect on cash?
- Alnylam Pharmaceuticals (ALNY) reported fx effect on cash of -$7.06M in Q1 2026.
- How has Alnylam Pharmaceuticals's fx effect on cash changed year-over-year?
- Alnylam Pharmaceuticals's fx effect on cash decreased by 150.2% year-over-year, from $14.06M to -$7.06M.
- What is the long-term trend for Alnylam Pharmaceuticals's fx effect on cash?
- Over 2 years (2021 to 2024), Alnylam Pharmaceuticals's fx effect on cash has grown at a 30.0% compound annual growth rate (CAGR), from -$9.02M to -$15.24M.
- What does fx effect on cash mean?
- The change in cash value caused by shifting foreign exchange rates.